{
    "title": "Roche haemophilia drug wins FDA nod, with a warning",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-5090163/Roche-haemophilia-drug-wins-FDA-nod-warning.html",
    "date": "2017-11-16",
    "keywords": [
        "hemlibra",
        "drug",
        "medicine",
        "blood",
        "year",
        "percent",
        "fda",
        "haemophilia",
        "drugmaker",
        "patent",
        "box",
        "resistance",
        "disorder",
        "treatment",
        "roche",
        "therapy",
        "success",
        "cancer",
        "food",
        "administration",
        "risk",
        "boost",
        "shire",
        "market",
        "ace910",
        "emicizumab",
        "injection",
        "clotting",
        "protein",
        "pillar",
        "ceo",
        "severin",
        "plan",
        "approval",
        "advancement",
        "bleeding",
        "havent",
        "horning",
        "officer",
        "company",
        "warning",
        "guidance",
        "thrombosis",
        "breakthrough",
        "safety",
        "profile",
        "adoption",
        "leadership",
        "field",
        "schwan",
        "pledge",
        "growth",
        "drop",
        "quarter",
        "turf",
        "arthritis",
        "rituxan",
        "avastin",
        "herceptin",
        "account",
        "bleed",
        "rate",
        "bypassing",
        "phase",
        "trial",
        "thursday",
        "lymphoma",
        "portfolio",
        "poll",
        "reporting",
        "john",
        "miller",
        "editing",
        "goodman",
        "dan",
        "grebler"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}